Evithé Biotechnology is a cutting-edge brand that is revolutionizing the global medicines toolbox. By harnessing the power of millions of years of plant evolution, Evithé is creating novel botanical drugs that aim to cure, mitigate, treat, or prevent diseases in humans. Inspired by the unique biodiversity of the South Pacific, Evithé is focused on developing high-value botanical drugs that cater to consumer preferences.

With a significant market pull, Evithé has found that 78% of consumers prefer botanical drugs over synthetic chemicals, and 70% of practitioners are confident in prescribing them. By collaborating with nature, Evithé utilizes the natural evolutionary processes of plants to deliver better treatment outcomes. Their mission is to support individuals with auto-inflammatory diseases, including conditions such as sepsis, rheumatoid arthritis, and interstitial cystitis.

Led by founder and CEO Cynthia Hunefeld, the talented team at Evithé includes experts in ethnobotany, clinical research, innovation, and commercialization. Alongside their seasoned executives and dedicated professionals, Evithé is driving rapid growth in the field of botanical drug development. Stay up to date with Evithé's groundbreaking advancements by connecting with them through their digital channels or reaching out to inquire about investment opportunities.

With their name embodying the essence of life, Evithé is truly at the forefront of botanical medicine